ResearcherMayo ClinicNo recent work listed

Ningling Kang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4565-7976; OpenAlex author ID A5015812063; NIH RePORTER profile ID 8254145. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2011: 1 grant · 2012: none · 2013: none · 2014: 1 paper

Papers 1

Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth. Co-author DOI 10.1016/j.ajpath.2014.06.023 ↗

Grants 1

Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors K01CA118722 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vijay H. Shah · 1 shared paper, 2014 · strength 0.04
- Paper Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes p… DOI 10.1016/j.ajpath.2014.06.023 ↗
Baoan Ji · 1 shared paper, 2014 · strength 0.04
- Paper Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes p… DOI 10.1016/j.ajpath.2014.06.023 ↗
Yan Bi · 1 shared paper, 2014 · strength 0.04
- Paper Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes p… DOI 10.1016/j.ajpath.2014.06.023 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.